The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders
Anna Alkelai(Regeneron (United States)), David B. Goldstein(Electronic BioSciences (United States)), Sahar Gelfman(Regeneron (United States)), Erin L. Heinzen(University of North Carolina at Chapel Hill), Anna R. Docherty(Virginia Commonwealth University), Andrey A. Shabalin(Virginia Commonwealth University), Bernard Lerer(Hebrew University of Jerusalem), Vaidehi Jobanputra(Columbia University Irving Medical Center), Anat Grossman-Jonish(Sheba Medical Center), Evan H. Baugh(Columbia University), Anthony W. Zoghbi(Baylor College of Medicine), Vimla S. Aggarwal(Columbia University Irving Medical Center), Lior Greenbaum(Tel Aviv University), Ann E. Pulver(Johns Hopkins University), Ayan Malakar(Columbia University Irving Medical Center), Hann-Shyan Hwang(National Taiwan University), Gundula Povysil(Bridgepoint (United States)), Daniel Hughes(Oxford University Hospitals NHS Trust), Shannon L. Delaney(New York Psychoanalytic Society and Institute), James McNamara(Harvard University), Matthew B. Harms(Columbia University), Emma P. Peabody(Harvard University)
Cited by 25
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
|Science|2015|5.7k
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
|Nature Reviews Genetics|2008|3k